Tetsu Akiyama

Prof. Dr. Tetsu Akiyama

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KTKenzui Taniue
Kenzui Taniue
AKAkiko Kurimoto
Akiko Kurimoto
HSHironobu Sugimasa
Hironobu Sugimasa
ENEmiko Nasu
Emiko Nasu
YTYasuko Takeda
Yasuko Takeda
TATetsu Akiyama
Tetsu Akiyama
Significance: Many long noncoding RNAs (lncRNAs) play critical roles in tumor development. Here we show that an lncRNA termed UPAT [ubiquitin-like plant homeodomain and really interesting new gene finger domain-containing protein 1 (UHRF1) Protein Associated Transcript] is required for the tumorigenicity of colorectal cancer cells. UPAT interacts with and stabilizes the epigenetic factor UHRF1 by interfering with its ubiquitination and degradation. Furthermore, the UHRF1– UPAT axis up-regulates Stearoyl-CoA desaturase 1 and Sprouty 4 , which are required for the survival of colon tumor cells. Our study provides evidence for an lncRNA that regulates protein ubiquitination and degradation and thereby plays a critical role in the survival and tumorigenicity of tumor cells. Our results suggest that UPAT and UHRF1 may be promising molecular targets for the therapy of colon cancer.

1 October 2014 in Cell Reports
Verified
Journal Article
Open access
HTHiroki Takai
Hiroki Takai
KMKoji Masuda
Koji Masuda
TSTomohiro Sato
Tomohiro Sato
YSYuriko Sakaguchi
Yuriko Sakaguchi
TSTakeo Suzuki
Takeo Suzuki
TATetsu Akiyama
Tetsu Akiyama
The development of cancer is driven not only by genetic mutations but also by epigenetic alterations. Here, we show that TET1-mediated production of 5-hydroxymethylcytosine (5hmC) is required for the tumorigenicity of glioblastoma cells. Furthermore, we demonstrate that chromatin target of PRMT1 (CHTOP) binds to 5hmC. We found that CHTOP is associated with an arginine methyltransferase complex, termed the methylosome, and that this promotes the PRMT1-mediated methylation of arginine 3 of histone H4 (H4R3) in genes involved in glioblastomagenesis, including EGFR, AKT3, CDK6, CCND2, and BRAF. Moreover, we found that CHTOP and PRMT1 are essential for the expression of these genes and that CHTOP is required for the tumorigenicity of glioblastoma cells. These results suggest that 5hmC plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex to selective sites on the chromosome, where it methylates H4R3 and activates the transcription of cancer-related genes.

1 March 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TOToshio Okabe
Toshio Okabe
TNTsutomu Nakamura
Tsutomu Nakamura
YNYukiko Nasu Nishimura
Yukiko Nasu Nishimura
KKKazuyoshi Kohu
Kazuyoshi Kohu
SOSusumu Ohwada
Susumu Ohwada
TATetsu Akiyama
Tetsu Akiyama
Cadherin adhesion molecules are believed to be important for synaptic plasticity. β-Catenin, which links cadherins and the actin cytoskeleton, is a modulator of cadherin adhesion and regulates synaptic structure and function. Here we show that β-catenin interacts with a novel GTPase-activating protein, named RICS, that acts on Cdc42 and Rac1. The RICS-β-catenin complex was found to be associated with N-cadherin,N-methyl-d-aspartate receptors, and postsynaptic density-95, and localized to the postsynaptic density. Furthermore, the GTPase-activating protein activity of RICS was inhibited by phosphorylation by Ca2+/calmodulin-dependent protein kinase II. These results suggest that RICS is involved in the synaptic adhesion- and N-methyl-d-aspartate-mediated organization of cytoskeletal networks and signal transduction. Thus, RICS may regulate dendritic spine morphology and strength by modulating Rho GTPases.

1 September 2016 in Cell Reports
Verified
Journal Article
Open access
YKYoshihiro Kawasaki
Yoshihiro Kawasaki
MKMimon Komiya
Mimon Komiya
KMKosuke Matsumura
Kosuke Matsumura
LNLumi Negishi
Lumi Negishi
SSSakiko Suda
Sakiko Suda
TATetsu Akiyama
Tetsu Akiyama
Aberrant activation of Wnt/β-catenin signaling is a major driving force in colon cancer. Wnt/β-catenin signaling induces the expression of the transcription factor c-Myc, leading to cell proliferation and tumorigenesis. c-Myc regulates multiple biological processes through its ability to directly modulate gene expression. Here, we identify a direct target of c-Myc, termed MYU, and show that MYU is upregulated in most colon cancers and required for the tumorigenicity of colon cancer cells. Furthermore, we demonstrate that MYU associates with the RNA binding protein hnRNP-K to stabilize CDK6 expression and thereby promotes the G1-S transition of the cell cycle. These results suggest that the MYU/hnRNP-K/CDK6 pathway functions downstream of Wnt/c-Myc signaling and plays a critical role in the proliferation and tumorigenicity of colon cancer cells.

1 September 2011 in Nature Communications
Verified
Journal Article
Open access
PDF file
KMKen Matsuura
Ken Matsuura
TJTakafumi Jigami
Takafumi Jigami
KTKenzui Taniue
Kenzui Taniue
YMYasuyuki Morishita
Yasuyuki Morishita
SAShungo Adachi
Shungo Adachi
TATetsu Akiyama
Tetsu Akiyama
Cell fusion has a critical role in various developmental processes, immune response, tissue homeostasis and regeneration, and possibly, in cancer. However, the signals that regulate cell fusion remain poorly understood. In a screen for novel targets of Wnt/β-catenin signalling, we identified glial cells missing 1 (GCM1), which encodes a transcription factor that is involved in epigenetic regulation and is critical for the fusion of syncytiotrophoblast (ST) cells. Here we show that β-catenin/BCL9-Like (BCL9L)/T-cell factor 4 (TCF4) signalling directly targets the GCM1/syncytin pathway and thereby regulates the fusion of human choriocarcinoma cells. Furthermore, we show that the GCM1/syncytin-B pathway is significantly downregulated in the placenta of BCL9L-deficient mice and that the fusion and differentiation of ST-II cells are blocked. Our results demonstrate a signal transduction pathway that regulates cell fusion, and may provide intriguing perspectives into the various biological and pathological processes that involve cell fusion.

1 December 2004 in Cancer Research
Verified
Journal Article
Open access
PDF file
SAShungo Adachi
Shungo Adachi
TJTakafumi Jigami
Takafumi Jigami
TYToshio Yasui
Toshio Yasui
TNTetsuhiro Nakano
Tetsuhiro Nakano
SOSusumu Ohwada
Susumu Ohwada
TATetsu Akiyama
Tetsu Akiyama
Wnt signaling plays a crucial role in a number of developmental processes and in tumorigenesis. β-Catenin is stabilized by Wnt signaling and associates with the TCF/LEF family of transcription factors, thereby activating transcription of Wnt target genes. Constitutive activation of β-catenin-TCF–mediated transcription resulting from mutations in adenomatous polyposis coli (APC), β-catenin, or Axin is believed to be a critical step in tumorigenesis among divergent types of cancers. Here we show that the transactivation potential of the β-catenin-TCF complex is enhanced by its interaction with a BCL9-like protein, B9L, in addition to BCL9. We found that B9L is required for enhanced β-catenin-TCF–mediated transcription in colorectal tumor cells and for β-catenin–induced transformation of RK3E cells. Furthermore, expression of B9L was aberrantly elevated in about 43% of colorectal tumors, relative to the corresponding noncancerous tissues. These results suggest that B9L plays an important role in tumorigenesis induced by aberrant activation of Wnt signaling.